MedPath
NMPA Approval

Alprostadil for Injection

H20181056

January 24, 2018

H20130418

Drug Information

注射用前列地尔

保达新

注射剂

20μg

化学药品

January 24, 2018

January 23, 2023

Company Information

Applicant Company

UCB Pharma GmbH

Alfred-Nobel-Str.10,40789 Monheim,Germany

Manufacturing Company

Bayer Pharma AG

Kaiser-Wilhelm-Allee 51368 Leverkusen,Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用前列地尔 - NMPA 批准文号 | MedPath